Effects of the Phosphodiesterase-5 (PDE-5) Inhibitors, Avanafil and Zaprinast, on Bone Remodeling and Oxidative Damage in a Rat Model of Glucocorticoid-Induced Osteoporosis

Huyut, Zübeyir; BAKAN, NURİ; YILDIRIM, Serkan; Alp, Hamit

doi:10.12659/msmbr.908504

Effects of the Phosphodiesterase-5 (PDE-5) Inhibitors, Avanafil and Zaprinast, on Bone Remodeling and Oxidative Damage in a Rat Model of Glucocorticoid-Induced Osteoporosis

Huyut Z., BAKAN N., YILDIRIM S., Alp H. H.

MEDICAL SCIENCE MONITOR BASIC RESEARCH, cilt.24, ss.47-58, 2018 (ESCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24
Basım Tarihi: 2018
Doi Numarası: 10.12659/msmbr.908504
Dergi Adı: MEDICAL SCIENCE MONITOR BASIC RESEARCH
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Sayfa Sayıları: ss.47-58
Anahtar Kelimeler: Bone Density, Dexamethasone, Osteoporosis, Phosphodiesterase 5 Inhibitors, NITRIC-OXIDE, MINERAL DENSITY, ANTIOXIDANT ACTIVITY, COENZYME Q(10), DNA-DAMAGE, STRESS, OVARIECTOMY, EXPRESSION, SUSCEPTIBILITY, METABOLISM
Erzincan Binali Yıldırım Üniversitesi Adresli: Hayır

Özet

Background: The aim of this study was to evaluate the effects of the phosphodiesterase-5 (PDE-5) inhibitors, zaprinast and avanafil, on NO signalling pathway, bone mineral density (BMD), epiphyseal bone width, bone marrow angiogenesis, and parameters of oxidative stress in a rat model of glucocorticoid-induced osteoporosis (GIOP).